Today, Berhringer Ingelheim Pharmaceuticals announced a recall of Pradaxa with an expiration of January 15, 2015. There is a risk of stroke and systemic embolism for those with non-valvular artrial fibrillation. One particular lot number is involved in this recall. A packaging defect resulted in the recall. Moisture might get into a bottle due to a bottling defect, resulting in a reduction in the quality of the 75mg Pradaxa. Patients are told to continue taking the product until they get a replacement. Details about this recall were sent to patients. Those who have not received information are asked to contact the company immediately, according to news reports.